Elliott P., Coppleson M., Russell P., Liouros P., Carter J., MacLeod C., Jones M.
Departments of Gynaecological Oncology, Anatomical Pathology and Radiation Oncology, King George V. (Royal Prince Alfred Hospital), Sydney and The Clinical Trials Center, University of Sydney, Sydney Australia.
Int J Gynecol Cancer. 2000 Jan;10(1):42-52. doi: 10.1046/j.1525-1438.2000.00011.x.
The clinical and histologic features of 476 tumors fitting the 1995 FIGO definition of stage IA cervical cancer, treated at a Sydney tertiary referral hospital between 1953 and 1992, are reviewed. Five-year follow-up was complete with a median of 10 years. The diagnosis was increasingly made by histologic examination of colposcopically directed cone biopsy. The majority (88%) of tumors were squamous. The proportion of both younger women (</=35 years) and adenocarcinoma and adenosquamous tumors increased during the second half of the study. Nearly half invaded 1 mm; a third 1.1-3 mm and 20% 3.1-5 mm. Lymph vascular space invasion (LVSI) increased with increasing depth of invasion and was present in over half the tumors invading >3 mm. Treatment was surgical in 99% and was increasingly more conservative as the study progressed with no apparent increase in treatment failure. From 1973 treatment by cone biopsy rose from 6.5 to 35%, by radical hysterectomy fell from 51 to 21% and by lymphadenectomy from 53 to 26%. Only one of 115 patients treated by cone biopsy died. Positive lymph nodes were detected in 1.7% of 180 patients undergoing lymphadenectomy. There were 16 recurrences (3.4%); six vaginal with no cancer deaths, nine pelvic and one distant, with nine deaths and three new cancers (two deaths). Univariate analysis suggests that older age, glandular tumors and those invading 3 mm were associated with more treatment failures and multivariate analysis showed that both conservative hysterectomy and the omission of lymphadenectomy are associated with higher recurrence rates with >3 mm invasion. The study failed to resolve the dilemma of predicting those tumors with a poor prognosis.
对1953年至1992年间在悉尼一家三级转诊医院接受治疗的476例符合1995年国际妇产科联盟(FIGO)IA期宫颈癌定义的肿瘤的临床和组织学特征进行了回顾。五年随访完整,中位随访时间为10年。诊断越来越多地通过阴道镜引导下锥形活检的组织学检查来做出。大多数(88%)肿瘤为鳞状细胞癌。在研究的后半期,年轻女性(≤35岁)以及腺癌和腺鳞癌肿瘤的比例均有所增加。近一半的肿瘤浸润深度达1毫米;三分之一浸润深度为1.1 - 3毫米,20%浸润深度为3.1 - 5毫米。淋巴血管间隙浸润(LVSI)随浸润深度增加而增加,在浸润深度>3毫米的肿瘤中,超过一半存在LVSI。99%的患者接受了手术治疗,随着研究进展,手术方式越来越保守,且治疗失败率无明显增加。从1973年起,锥形活检治疗率从6.5%升至35%,根治性子宫切除术治疗率从51%降至21%,淋巴结切除术治疗率从53%降至26%。接受锥形活检治疗的115例患者中仅1例死亡。在接受淋巴结切除术的180例患者中,1.7%检测到阳性淋巴结。有16例复发(3.4%);6例为阴道复发,无癌症死亡,9例为盆腔复发,1例为远处复发,9例死亡,3例新发癌症(2例死亡)。单因素分析表明,年龄较大、腺性肿瘤以及浸润深度达3毫米的肿瘤与更多治疗失败相关,多因素分析显示,对于浸润深度>3毫米的肿瘤,保守性子宫切除术和未行淋巴结切除术均与较高的复发率相关。该研究未能解决预测预后不良肿瘤的难题。